Hematology focuses on diseases of the blood, bone marrow, and lymphatic system. Learn about the diagnosis and treatment of anemia, leukemia, and lymphoma.
Send us all your questions or requests, and our expert team will assist you.
The diagnosis and evaluation of anemia is a critical step in identifying the underlying cause and guiding effective treatment, especially for international patients seeking specialized care. Anemia affects nearly 1.6 billion people worldwide, making accurate assessment essential for health outcomes. This page is designed for patients, caregivers, and referring physicians who need a clear, step‑by‑step overview of how anemia is investigated at Liv Hospital. We will explore clinical signs, laboratory investigations, advanced imaging, result interpretation, and how our multidisciplinary team creates a personalized care plan.
From the initial consultation to the final treatment recommendation, every phase of the diagnosis and evaluation process is tailored to the individual’s medical history, lifestyle, and travel considerations. Whether you are preparing for a visit from abroad or coordinating care with a local provider, understanding each component will empower you to make informed decisions and ensure a smooth journey through the healthcare system.
Patients with anemia often present with a range of nonspecific symptoms that can be easily overlooked. The first step in the diagnosis and evaluation process involves a thorough clinical interview and physical examination.
During the exam, clinicians assess:
A detailed medical history—including dietary habits, menstrual patterns, chronic diseases, medication use, and family history—helps narrow the differential diagnosis before laboratory testing begins.
Laboratory investigations provide the objective data needed to confirm anemia and begin the process of pinpointing its cause. Below is a concise table of the most commonly ordered tests and their diagnostic relevance.
Additional specialized tests—such as bone‑marrow biopsy, electrophoresis for hemoglobinopathies, and renal function panels—are ordered when initial results point toward complex or rare conditions.
When laboratory data alone cannot explain the anemia, advanced diagnostic modalities become essential. These tools are integrated into the comprehensive diagnosis and evaluation workflow at Liv Hospital.
All imaging and specialized studies are performed using state‑of‑the‑art equipment, and results are reviewed by a multidisciplinary team that includes hematologists, radiologists, and pathologists.
Accurate interpretation of test results is the cornerstone of effective treatment planning. The following decision framework helps clinicians differentiate the most common categories of anemia.
Each category guides specific therapeutic interventions, ranging from oral iron supplementation to targeted biologic agents for autoimmune hemolysis. Our physicians also consider patient‑specific factors such as comorbidities, pregnancy status, and travel plans when finalizing the diagnosis.
After establishing the precise cause of anemia, Liv Hospital creates a customized care plan that aligns with the patient’s health goals and logistical needs.
Our international patient services team assists with appointment coordination, interpreter support, and travel logistics, ensuring that patients from any country experience seamless continuity of care from admission through discharge.
Liv Hospital is a JCI‑accredited, internationally recognized medical center in Istanbul, offering a full suite of hematology services for patients worldwide. Our multidisciplinary team combines expertise in cutting‑edge diagnostics with compassionate, culturally sensitive care. International patients benefit from comprehensive support—including visa assistance, airport transfers, interpreter services, and comfortable accommodation options—so that the focus remains on healing. With a proven track record in managing complex anemia cases, Liv Hospital delivers personalized treatment plans that meet the highest global standards.
Ready to take the next step in your anemia care journey? Contact Liv Hospital today to schedule a comprehensive evaluation and experience world‑class, patient‑focused treatment.
Our dedicated international patient team is standing by to assist with appointments, travel arrangements, and any questions you may have.
Send us all your questions or requests, and our expert team will assist you.
Anemia often presents with nonspecific signs that can be easily missed. Patients frequently report persistent fatigue and generalized weakness that interfere with daily activities. Physical signs such as pallor of the skin, mucous membranes, conjunctiva, and nail beds are classic. Cardiovascular symptoms like tachycardia and shortness of breath on exertion occur as the body tries to compensate for reduced oxygen-carrying capacity. Dizziness or light‑headedness and cold hands or feet are also common, especially in severe cases. Recognizing this constellation of symptoms is the first step in prompting a clinical evaluation for anemia.
When laboratory data are insufficient, imaging becomes pivotal. Abdominal ultrasound evaluates spleen and liver size, helping identify splenomegaly or hepatic pathology that may contribute to anemia. Magnetic Resonance Imaging (MRI) provides detailed bone‑marrow assessment, useful in suspected myelodysplastic syndromes or marrow infiltration. Computed Tomography (CT) scans are used to locate gastrointestinal bleeding, tumors, or lymphadenopathy that could cause chronic blood loss. All imaging studies are interpreted by a multidisciplinary team of hematologists, radiologists, and pathologists to integrate findings into the overall diagnostic algorithm.
Interpretation follows a decision framework. Microcytic, hypochromic patterns with low ferritin point to iron‑deficiency or thalassemia. Normocytic, normochromic results with elevated inflammatory markers suggest anemia of chronic disease or renal insufficiency. Macrocytic anemia with high MCV and low B12 or folate indicates megaloblastic causes. Hemolytic anemia is identified by elevated LDH, indirect bilirubin, low haptoglobin, and reticulocytosis, often confirmed with a Coombs test. Patient history—including diet, menstrual losses, chronic illnesses, medications, and family genetics—refines the differential diagnosis before finalizing treatment.
ALL diagnosis combines laboratory and imaging studies. A complete blood count with differential reveals abnormal white cell counts, while a peripheral smear shows blasts. Bone‑marrow aspiration and biopsy confirm leukemia, and flow cytometry characterizes the immunophenotype. Cytogenetic and molecular analyses detect chromosomal abnormalities such as the Philadelphia chromosome. Staging differs from solid tumors; patients are classified into risk categories (standard, high, very high) based on age, white‑blood‑cell count at diagnosis, and genetic features. This risk stratification guides therapy intensity.
Understanding the challenges faced by patients traveling from abroad, Liv Hospital’s international patient services team assists with every logistical step. They help obtain medical visas, arrange airport pick‑up, and provide professional interpreters fluent in multiple languages. Comfortable on‑site accommodation and dietary services are available for extended stays. A dedicated patient liaison coordinates appointments, ensures timely communication of test results, and facilitates tele‑consultations with local physicians after discharge. This comprehensive support allows patients to focus on their health while receiving world‑class, culturally sensitive care.
Prognosis varies by age, genetics, and treatment response. Pediatric patients (1‑10 years, standard risk) achieve approximately 90% five‑year survival due to effective chemotherapy protocols. Adolescents and young adults see 70‑80% survival, while adults over 30 years with high‑risk features have lower rates of 40‑50%. The presence of the Philadelphia chromosome historically worsened outcomes, but the addition of tyrosine‑kinase inhibitors improves five‑year survival to about 55%. Ongoing monitoring for late effects and survivorship programs are essential components of long‑term care.
BlogHematologyFeb 19, 2026A complete blood count is a common test to check overall health. It helps find issues like anemia, infectio...
BlogHematologyFeb 19, 2026Thin blood, also known as thrombocytopenia, happens when you have too few platelets. Platelets help your bl...
BlogHematologyFeb 19, 2026Hemophilia is a genetic disorder that makes it hard for the body to form blood clots. It affects people all...
BlogAnemiaFeb 19, 2026Are you always tired, dizzy, or have brittle nails? Poor iron absorption might be the reason. It’s a ...
BlogHematologyFeb 19, 2026The Rule of Three is key in hematology. It helps labs check if a complete blood count (CBC) is right. It sa...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
